69 research outputs found
Polytechnic Instructors as Scholars: Developing a Culture that Embraces Scholarly Activity
This Organizational Improvement Plan (OIP) proposes a leadership solution to develop a culture that embraces faculty scholarly activity at a large Canadian polytechnic institution. The recent advent of two baccalaureate degrees at this diploma-offering institute brought with it the provincial government stipulation that faculty teaching in degree programs must be continually engaged in scholarly activity. A previous unsuccessful implementation of this requirement addressed the functional, managerial aspects of conducting research, however faculty were unprepared for the cultural shift necessary to transform them from polytechnic instructors to scholarly polytechnic instructors. Though the requirement to research remains, early attempts at support have been abandoned, leaving degree faculty and their academic chairs adrift.
By creating a centralized institutional research hub and involving stakeholders in the process, material and informational supports would then help shift the scholarly culture towards acceptance and compliance. This OIP underscores the importance of following a prescribed change leadership process that considers both the strategic and cultural aspects of change (Bolman & Deal, 2013; Harris, 1996; Kezar, 2014; Martin, 1992: Prosci, 2016). It couches these ideas and proposals in consideration of the existing, predominant governance structure at the institute, one of transformational, distributed, and ethical leadership (Gaubatz & Ensminger, 2015; House, 1971; Kidder, 1995; Kotter, 2007; Northouse, 2016).
This OIP may be adapted to similar contexts at similar institutions, as well as to other change leadership problems where the tendency has been to focus on strategy rather than strategy + cultural change.
Keywords: scholarly activity, research, culture, faculty, instructors, polytechnic, problem of practice, transformational leadership, distributed leadershi
A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics
Background: Genome-wide data are increasingly important in the clinical evaluation of human disease. However, the large number of variants observed in individual patients challenges the efficiency and accuracy of diagnostic review. Recent work has shown that systematic integration of clinical phenotype data with genotype information can improve diagnostic workflows and prioritization of filtered rare variants. We have developed visually interactive, analytically transparent analysis software that leverages existing disease catalogs, such as the Online Mendelian Inheritance in Man database (OMIM) and the Human Phenotype Ontology (HPO), to integrate patient phenotype and variant data into ranked diagnostic alternatives. Methods: Our tool, âOMIM Explorerâ (http://www.omimexplorer.com), extends the biomedical application of semantic similarity methods beyond those reported in previous studies. The tool also provides a simple interface for translating free-text clinical notes into HPO terms, enabling clinical providers and geneticists to contribute phenotypes to the diagnostic process. The visual approach uses semantic similarity with multidimensional scaling to collapse high-dimensional phenotype and genotype data from an individual into a graphical format that contextualizes the patient within a low-dimensional disease map. The map proposes a differential diagnosis and algorithmically suggests potential alternatives for phenotype queriesâin essence, generating a computationally assisted differential diagnosis informed by the individualâs personal genome. Visual interactivity allows the user to filter and update variant rankings by interacting with intermediate results. The tool also implements an adaptive approach for disease gene discovery based on patient phenotypes. Results: We retrospectively analyzed pilot cohort data from the Baylor Miraca Genetics Laboratory, demonstrating performance of the tool and workflow in the re-analysis of clinical exomes. Our tool assigned to clinically reported variants a median rank of 2, placing causal variants in the top 1 % of filtered candidates across the 47 cohort cases with reported molecular diagnoses of exome variants in OMIM Morbidmap genes. Our tool outperformed Phen-Gen, eXtasy, PhenIX, PHIVE, and hiPHIVE in the prioritization of these clinically reported variants. Conclusions: Our integrative paradigm can improve efficiency and, potentially, the quality of genomic medicine by more effectively utilizing available phenotype information, catalog data, and genomic knowledge
Characterisation of a rare, reassortant human G10P[14] rotavirus strain detected in Honduras
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors
<p>Abstract</p> <p>Background</p> <p>The Ras-dependent ERK1/2 MAP kinase signaling pathway plays a central role in cell proliferation control and is frequently activated in human colorectal cancer. Small-molecule inhibitors of MEK1/MEK2 are therefore viewed as attractive drug candidates for the targeted therapy of this malignancy. However, the exact contribution of MEK1 and MEK2 to the pathogenesis of colorectal cancer remains to be established.</p> <p>Methods</p> <p>Wild type and constitutively active forms of MEK1 and MEK2 were ectopically expressed by retroviral gene transfer in the normal intestinal epithelial cell line IEC-6. We studied the impact of MEK1 and MEK2 activation on cellular morphology, cell proliferation, survival, migration, invasiveness, and tumorigenesis in mice. RNA interference was used to test the requirement for MEK1 and MEK2 function in maintaining the proliferation of human colorectal cancer cells.</p> <p>Results</p> <p>We found that expression of activated MEK1 or MEK2 is sufficient to morphologically transform intestinal epithelial cells, dysregulate cell proliferation and induce the formation of high-grade adenocarcinomas after orthotopic transplantation in mice. A large proportion of these intestinal tumors metastasize to the liver and lung. Mechanistically, activation of MEK1 or MEK2 up-regulates the expression of matrix metalloproteinases, promotes invasiveness and protects cells from undergoing anoikis. Importantly, we show that silencing of MEK2 expression completely suppresses the proliferation of human colon carcinoma cell lines, whereas inactivation of MEK1 has a much weaker effect.</p> <p>Conclusion</p> <p>MEK1 and MEK2 isoforms have similar transforming properties and are able to induce the formation of metastatic intestinal tumors in mice. Our results suggest that MEK2 plays a more important role than MEK1 in sustaining the proliferation of human colorectal cancer cells.</p
Atmospheric electrification in dusty, reactive gases in the solar system and beyond
Detailed observations of the solar system planets reveal a wide variety of local atmospheric conditions. Astronomical observations have revealed a variety of extrasolar planets none of which resembles any of the solar system planets in full. Instead, the most massive amongst the extrasolar planets, the gas giants, appear very similar to the class of (young) Brown Dwarfs which are amongst the oldest objects in the universe. Despite of this diversity, solar system planets, extrasolar planets and Brown Dwarfs have broadly similar global temperatures between 300K and 2500K. In consequence, clouds of different chemical species form in their atmospheres. While the details of these clouds differ, the fundamental physical processes are the same. Further to this, all these objects were observed to produce radio and X-ray emission. While both kinds of radiation are well studied on Earth and to a lesser extent on the solar system planets, the occurrence of emission that potentially originate from accelerated electrons on Brown Dwarfs, extrasolar planets and protoplanetary disks is not well understood yet. This paper offers an interdisciplinary view on electrification processes and their feedback on their hosting environment in meteorology, volcanology, planetology and research on extrasolar planets and planet formation
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 Ă 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist
The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy
Background: The ability to accurately predict operative duration has the potential to optimise theatre efficiency and utilisation, thus reducing costs and increasing staff and patient satisfaction. With laparoscopic cholecystectomy being one of the most commonly performed procedures worldwide, a tool to predict operative duration could be extremely beneficial to healthcare organisations.
Methods: Data collected from the CholeS study on patients undergoing cholecystectomy in UK and Irish hospitals between 04/2014 and 05/2014 were used to study operative duration. A multivariable binary logistic regression model was produced in order to identify significant independent predictors of long (>â90 min) operations. The resulting model was converted to a risk score, which was subsequently validated on second cohort of patients using ROC curves.
Results: After exclusions, data were available for 7227 patients in the derivation (CholeS) cohort. The median operative duration was 60 min (interquartile range 45â85), with 17.7% of operations lasting longer than 90 min. Ten factors were found to be significant independent predictors of operative durations >â90 min, including ASA, age, previous surgical admissions, BMI, gallbladder wall thickness and CBD diameter. A risk score was then produced from these factors, and applied to a cohort of 2405 patients from a tertiary centre for external validation. This returned an area under the ROC curve of 0.708 (SEâ=â0.013, pââ90 min increasing more than eightfold from 5.1 to 41.8% in the extremes of the score.
Conclusion: The scoring tool produced in this study was found to be significantly predictive of long operative durations on validation in an external cohort. As such, the tool may have the potential to enable organisations to better organise theatre lists and deliver greater efficiencies in care
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Distribution and Cconnection to other Plant-Communities of Genista radiata (L.) Scop in the South Tyrol (Italy)
Es werden die Genista radiata-BestĂ€nde an der Mendel in SĂŒdtirol (Italien) beschrieben und ihr GesellschaftsanschluĂ diskutiert. Das Genisto-Festucetum alpestris Peer 83 besidelt steile sĂŒdexponierte KalkhĂ€nge der hochmontanen und subalpinen Stufe und ersetzt z.T. den ZwergstrauchgĂŒrtel mit Pinus mugo. Ăhnlich zusammengesetzt ist das Genisto-Festucetum alpestris pinetosum Peer 83, das in den ÂĄlockeren Erika-KiefernwĂ€ldern auftritt und bis in die tiefmontane Stufe hinunterreicht. Keinerlei syntaxonomische Bedeutung besitzt Genista radiata in den thermophilen Buschwaldgesellschaften, in denen die Pflanze lediglich eine Variante zum Orno-Ostryetum seslerietosum Peer 81 darstellt und speziell in der Saumzone anzutreffen ist. Auch in den LĂ€rchenwiesen der Kammlagen kommt Genista radiata nur sporadisch vor. Sie ist hier mit dem Festucetum nigrescentis laricetosum subass. prov. verzahnt.IstraĆŸene su vegetacijske sastojine vrste Genista radiata u juĆŸnom Tirolu i razmatrana njihova fitocenoloĆĄka pripadnost. Asocijacija Genisto-Festucetum alpestris Peer 83 nastava strme, juĆŸne vapnenaÄke obronke visokobrdskog i subalpskog pojasa. Subasocijacija Genisto-Festucetum alpestris pinetosum Peer 83 dolazi u rijetkim borovim ĆĄumama s crnjuĆĄom i spuĆĄta se do u niĆŸi brdski pojas. Termofilne niske ĆĄume, u kojima Genista radiata nema posebno sintaksonomsko znaÄenje, oznaÄene su samo kao varijanta zajednice Orno-Ostryetum seslerietosum Peer 81. Genista radiata dolazi takoÄer na travnjacima s ariĆĄem, ali samo sporadiÄno i to u mjeĆĄavini sa zajednicom Festucetum nigrescentis laricetosnm subass. prov.The Genista radiata-communities of the Mendel in the South Tyrol (Italy) are described and their connection to other plant-communities is discussed. Genisto-Festucetum alpestris Peer 83 settles on steep, south- exposed colcareous slopes of high-mountain and subalpine altitudes and replaces particularly the dwarf-shrub-belt with Firms mugo. Similar contents aire found in Genisto-F estucetum alpestris pinetasum Peer 83, which occurs in undensed Erico-Pinetum-communities and reaches down to the low-mountain-altitude. In the thermophilic bush-communities, in which Genista radiata is found only as a variant of Orneto-Ostryetum seslerie- tosum (Peer 81), the plant has no syntaxonomic importance. Genista radiata especially is found in the edge-zone. In the grassland of the larch- communities of the ridges Genista radiata appears only sporadically. Here the plant appeals in Festucetum nigrescentis laricetosum subass. prov
Recommended from our members
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (nâ=â143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (nâ=â152), or no hydrocortisone (nâ=â108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (nâ=â137), shock-dependent (nâ=â146), and no (nâ=â101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707
- âŠ